Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl

Lignende værker

• Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant
  af: Jin, Bei, et al.
  Udgivet: (2018)
• Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia
  af: Sun, Xiaoyan, et al.
  Udgivet: (2016)
• Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias
  af: Nicolini, Franck Emmanuel, et al.
  Udgivet: (2011)
• Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia
  af: Yusoff, Yuslina Mat, et al.
  Udgivet: (2018)
• Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutation
  af: Okabe, Seiichi, et al.
  Udgivet: (2015)